6148
G. Sabitha et al. / Tetrahedron Letters 46 (2005) 6145–6148
3464–3474; (b) Leonard, M. S.; Carroll, P. J.; Joullie, M.
M. J. Org. Chem. 2004, 69, 2526–2531.
allowed macrolactonization to proceed to give the
saturated analogue I21 of pondaplin in good yield
(Scheme 4).
15. Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405–
4407.
16. Compound 18: 1H NMR (200 MHz, CDCl3): d 1.88 (s,
3H, –CH3), 4.18 (s, 2H, –OCH2), 4.58 (d, J = 6.7 Hz, 2H,
–OCH2), 5.65 (t, 1H, J = 6.8 Hz), 5.82 (d, 1H,
J = 12.6 Hz), 6.82 (d, 2H, J = 8.9 Hz, ArH), 6.92 (d, 1H,
J = 12.6 Hz), 7.66 (d, 2H, J = 8.9 Hz, ArH).
Another pondaplin analogue II was synthesized from
saturated ester 24 (Scheme 5). Compound 24 was sub-
jected to alkylation with prenyl bromide to afford O-pre-
nyl ether 28 in 92% yield. Further allylic oxidation was
achieved using SeO2 to afford E-aldehyde 29. The alde-
hyde was reduced with NaBH4 in MeOH to give the cor-
responding E-allylic alcohol 30 in 85% yield. Ester
hydrolysis followed by intramolecular cyclization with
DCC/DMAP in CH2Cl2 at 0 °C afforded the saturated
analogue II (Scheme 5).22
1
17. Dimer: mp 142–146 °C; IR (KBr): 1710 cmꢀ1; H NMR
(200 MHz, CDCl3): d 1.80 (s, 6H, –CH3), 4.60 (br s, 8H,
–OCH2), 5.62 (t, 2H, J = 6.8 Hz), 6.50 (d, 2H,
J = 14.8 Hz, H-8), 6.80 (d, 4H, J = 8.8 Hz, ArH), 7.39
(d, 4H, J = 8.8 Hz, ArH), 7.60 (d, 2H J = 15.6 Hz, H-7).
13C NMR (75MHz, CDCl 3): d 166.0, 160.2, 143.3, 137.6,
127.5, 127.2, 122.6, 119.6, 114.0, 68.5, 65.8, 20.3. FAB
Mass: 461 (M+1).
In conclusion, syntheses of two pondaplin analogues
have been achieved. Further studies directed toward
the total synthesis of pondaplin 1 are currently under-
way in our laboratory and the results of these investiga-
tions will be reported in due course.
18. Cheng, Q.; Zhang, Y. W.; Zhang, X.; Oritani, T. Chin.
Chem. Lett. 2003, 14, 1215–1218.
19. Compound 20: liquid, 1H NMR (200 MHz, CDCl3): d
1.88 (s, 3H, –CH3), 3.81 (s, 2H, –CH2Br), 4.72 (d, 2H, J =
6.7 Hz, –OCH2), 4.78 (s, 2H, –OCH2), 5.72 (t, 1H,
J = 6.8 Hz), 6.98 (d, 2H, J = 8.9 Hz, ArH), 7.82 (d, 2H,
J = 8.9 Hz, ArH), 9.89 (s, 1H, –CHO).
20. Compound 21: mp. 67–70 °C, IR (KBr): 1709 cmꢀ1 1H
;
Acknowledgements
NMR (200 MHz, CDCl3): d 1.33 (t, 3H, J = 7.1 Hz,
–CH2CH3), 1.88 (s, 3H, –CH3), 4.21 (s, 2H, –OCH2), 4.26
(q, 2H, J = 7.1, 14.2 Hz, –OCH2CH3), 4.60 (d, 2H,
J = 6.7 Hz, –OCH2), 5.6 (t, 1H, J = 6.8 Hz, olefinic),
6.25(d, 1H, J = 15.8 Hz), 6.80 (d, 2H, J = 8.7 Hz, ArH),
7.42 (d, 2H, J = 8.7 Hz, ArH), 7.60 (d, 1H, J = 15.8 Hz);
13C NMR (75MHz, CDCl 3): 167.29, 160.3, 144.1, 140.9,
129.6, 127.4, 122.2, 115.9, 115.0, 64.0, 61.9, 60.3, 21.3,
14.3; FAB Mass: 277 (M+1).
R.S. and R.S.B. thank CSIR, New Delhi, for their
fellowships.
References and notes
1. Liu, X.-X.; Pilarinou, E.; McLaughlin, J. L. Tetrahedron
Lett. 1999, 40, 399–402.
2. Ohsawa, K.; Atsuzawa, S.; Mitsui, T.; Yamamoto, I.
J. Pesticide Sci. 1991, 16, 93–96.
3. Padmaja, V.; Thankamany, K.; Hara, N.; Fujimoto, Y.;
Hisham, A. J. Ethnopharmacol. 1995, 48, 21–24.
4. Liu, X.; Alali, F. Q.; Craig, D. C.; Rogers, L.; Pilarinou,
E.; McLaughlin, J. L. Bioorg. Med. Chem. 1998, 6, 959–
966.
5. Liu, X.; Alali, F. Q.; Pilarinou, E.; McLaughlin, J. L.
J. Nat. Prod. 1998, 61, 620–624.
6. Liu, X.; Alali, F. Q.; Pilarinou, E.; McLaughlin, J. L.
J. Phytochem. 1999, 50, 815–821.
7. Ducki, S.; Hadfield, J. A.; Lawrence, N. J.; Liu, C.-Y.;
McGown, A. T.; Zhang, X. Planta Med. 1996, 62, 185–
186.
8. Ojewole, J. A. O.; Adesina, S. K. Planta Med. 1983, 49,
46–50.
9. Perez, C.; Almonacid, L. N.; Trujillo, J. M.; Gonzalez, A.
G.; Alonso, S. J.; Navarro, E. Planta Med. 1995, 61, 535–
536.
10. Kitarawa, S.; Tsukomoto, H.; Hisada, S.; Nhisibe, S.
Chem. Pharm. Bull. 1984, 32, 1209–1213.
11. Hussein, M.; Samuelsson, G. Planta Med. 1992, 58, 14–
18.
12. Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34,
18–29.
13. Bressy, C.; Piva, O. Synlett 2003, 87–90.
14. (a) Nakata, M.; Ohashi, J.; Ohsawa, K.; Nishimura, T.;
Kinoshita, M.; Tatsuta, K. Bull. Chem. Soc. Jpn. 1993, 66,
21. Preparation of saturated analogue I: To a stirred solution
of N,N0-dicyclohexylcarbodiimide (DCC) (1.4 mmol) and
N,N-dimethylaminopyridine (DMAP) (1.4 mmol) in dry
CH2Cl2 at 0 °C was added a solution of 27 in CH2Cl2
slowly and the mixture allowed to stir at rt for 12 h.
Precipitated urea was then filtered off and the filtrate was
washed twice with 0.5N HCl and with saturated NaHCO 3
solution and then dried over MgSO4. The solvent was
removed by evaporation and the residue was purified by
silica gel column chromatography (hexane/ethyl acetate,
8:2) to afford saturated analogue I in 55% yield. mp 123–
125 °C; IR (KBr): 1733 cmꢀ1
;
1H NMR (200 MHz,
CDCl3): d 1.80 (s, 3H, –CH3), 2.61 (t, 2H, J = 7.5Hz,
–CH2CH2), 2.90 (t, 2H, J = 8.3 Hz, –CH2CO), 4.51 (d,
2H, J = 6.6 Hz, –OCH2), 4.60 (s, 2H, –OCH2), 5.65 (t, 1H,
J = 5.7 Hz, olefinic), 6.78 (d, J = 8.9 Hz, 2H, ArH), 7.08
(d, 2H, J = 8.9 Hz, ArH); 13C NMR (75MHz, CDCl 3): d
173.2, 157.0, 139.7, 132.5, 129.0, 119.8, 114.5, 70.8, 67.4,
35.7, 29.9, 19.3; FAB Mass: 233 (M+1).
22. Preparation of saturated analogue II: procedure same as
above from 31. Mp 119–121 °C; IR (KBr): 1733 cmꢀ1; 1H
NMR (300 MHz, CDCl3): d 1.80 (s, 3H, –CH3), 2.61 (t,
2H, J = 7.5Hz, –CH2CH2), 2.90 (t, 2H, J = 8.3 Hz,
–CH2CO), 4.55 (d, J = 6.0 Hz, 2H, –OCH2), 4.61 (s, 2H,
–OCH2), 5.65 (t, 1H, J = 5.2 Hz, olefinic), 6.78 (d, 2H,
J = 8.9 Hz, ArH), 7.06 (d, 2H, J = 8.9 Hz, ArH); 13C
NMR (75MHz, CDCl 3): d 173.2, 157.0, 137.7, 132.5,
129.0, 119.8, 114.5, 75.1, 67.4, 35.7, 29.9, 13.7; FAB Mass:
233 (M+1).